MiNK Therapeutics, Inc. (INKT) › Shareholders' EquityMiNK Therapeutics, Inc. (INKT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$36.33M2020: -$53.87M2021: $23.78M2022: -$401.3K2023: -$18.06M2024: -$19.59M2025: -$14.23M-$14.23M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$14.23M+27.4%2024-$19.59M-8.5%2023-$18.06M-4399.2%2022-$401.3K-101.7%2021$23.78M+144.1%2020-$53.87M-48.3%2019-$36.33M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share